表紙
市場調查報告書

模組型實驗室自動化的全球市場:2020年∼2024年

Modular Laboratory Automation Market by End-users and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 919323
出版日期 內容資訊 英文 169 Pages
訂單完成後即時交付
價格
Back to Top
模組型實驗室自動化的全球市場:2020年∼2024年 Modular Laboratory Automation Market by End-users and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年11月29日內容資訊: 英文 169 Pages
簡介

模組型實驗室自動化市場上,在臨床及診斷實驗室的工作負擔增加,及索引實驗室間的自動化的需求等成為成長促進因素,在預測期間內預計將以6%以上的年複合成長率擴大。但,現有的實驗室空間的自動化系統的實行整合,高額的資本投資的必要條件,及自動化的失敗造成長期的停機時間的風險等要素,可能妨礙在預測期間內模組型實驗室自動化產業的成長。

本報告提供全球模組型實驗室自動化市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場規模及預測(2019年∼2024年)
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 各終端用戶比較:市場規模及預測(2019年∼2024年)
  • 醫院及診斷研究所
  • 製藥及生物科技企業
  • 其他終端用戶
  • 市場機會:各終端用戶

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 自動化量容許量及STAT檢驗次序的採用增加
  • 實驗室的工作流程的AI與分析工具的整合
  • 模組型實驗室自動化的標準化

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Agilent Technologies Inc.
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • QIAGEN NV
  • 島津製作所
  • Siemens AG
  • Thermo Fisher Scientific Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40241

About this market

Technavio's modular laboratory automation market analysis considers sales from hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, and other end-users. Our study also finds the sales of modular laboratory automation in Asia, Europe, North America, and ROW. In 2019, the hospitals and diagnostic laboratories segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as growing prevalence of chronic and infectious diseases such as cancer, diabetes, influenza, and cardiovascular will play a significant role in the hospitals and diagnostic laboratories segment to maintain its market position. Also, our global modular laboratory automation market report looks at factors such as increasing workload in clinical and diagnostic laboratories, and demand for automation among reference laboratories. However, implementation and integration of automated systems into existing laboratory space, requirement for high capital investments, and risk of prolonged downtime due to automation failure may hamper the growth of the modular laboratory automation industry over the forecast period.

Overview

Rising drug development and research activities

The drug R&D sector is witnessing rapid growth with the increase in drug discovery activities and approvals. Drug discovery activities involve safety testing procedures such as validation testing, pharmacogenomic testing, and toxicity testing. This is encouraging drug development researchers to use automation technologies, which are used in safety testing procedures to automate the preanalytical and post-analytical processing. It enhances the process by developing a streamlined workflow and minimizing manual intervention. Thus, the rise in drug development and research activities will lead to the expansion of the global modular laboratory automation market at a CAGR of over 6% during the forecast period.

Integration of AI and analytical tools in laboratory workflow

Vendors are finding automation and Al as complementing technologies that are together ensuring the optimum utilization of laboratory resources and helping in increasing productivity. The integration of Al and analytical tools has resulted in the introduction of smart modular laboratory automation solutions, which have allowed easy, reliable, and secured networking of automated modules at the field level. Additionally, features such as intelligent control and real-time update about the economic consumption of water and raw materials help provide significant cost benefits to the laboratories deploying such smart systems. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global modular laboratory automation market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of a few major players, the global modular laboratory automation market is concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading modular laboratory automation manufacturers, that include Agilent Technologies Inc., Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., QIAGEN NV, Shimadzu Corp., Siemens AG, and Thermo Fisher Scientific Inc.

Also, the modular laboratory automation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals and diagnostic laboratories - Market size and forecast 2019-2024
  • Pharmaceutical and biotechnology companies - Market size and forecast
  • 2019-2024
  • Other end-users - Market size and forecast 2019-2024
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing adoption of automated high-throughput and STAT testing
  • procedures
  • Integration of AI and analytical tools in laboratory workflow
  • Standardization among modular laboratory automation solutions

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Shimadzu Corp.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global life sciences tools and services market
  • Exhibit 02: Segments of global life sciences tools and services market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendor offering
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: End-user - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Hospitals and diagnostic laboratories - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Hospitals and diagnostic laboratories - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Pharmaceutical and biotechnology companies - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Other end-users - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 25: Other end-users - Year-over-year growth 2020-2024 (%)
  • Exhibit 26: Market opportunity by end-user
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2019-2024 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 37: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 38: Key leading countries
  • Exhibit 39: Market opportunity
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Agilent Technologies Inc. - Vendor overview
  • Exhibit 47: Agilent Technologies Inc. - Business segments
  • Exhibit 48: Agilent Technologies Inc. - Organizational developments
  • Exhibit 49: Agilent Technologies Inc. - Geographic focus
  • Exhibit 50: Agilent Technologies Inc. - Segment focus
  • Exhibit 51: Agilent Technologies Inc. - Key offerings
  • Exhibit 52: Becton, Dickinson and Co. - Vendor overview
  • Exhibit 53: Becton, Dickinson and Co. - Business segments
  • Exhibit 54: Becton, Dickinson and Co. - Organizational developments
  • Exhibit 55: Becton, Dickinson and Co. - Geographic focus
  • Exhibit 56: Becton, Dickinson and Co. - Segment focus
  • Exhibit 57: Becton, Dickinson and Co. - Key offerings
  • Exhibit 58: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 59: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 60: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 61: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 62: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 63: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 64: Danaher Corp. - Vendor overview
  • Exhibit 65: Danaher Corp. - Business segments
  • Exhibit 66: Danaher Corp. - Organizational developments
  • Exhibit 67: Danaher Corp. - Geographic focus
  • Exhibit 68: Danaher Corp. - Segment focus
  • Exhibit 69: Danaher Corp. - Key offerings
  • Exhibit 70: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 71: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 72: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 73: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 74: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 75: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 76: PerkinElmer Inc. - Vendor overview
  • Exhibit 77: PerkinElmer Inc. - Business segments
  • Exhibit 78: PerkinElmer Inc. - Organizational developments
  • Exhibit 79: PerkinElmer Inc. - Geographic focus
  • Exhibit 80: PerkinElmer Inc. - Segment focus
  • Exhibit 81: PerkinElmer Inc. - Key offerings
  • Exhibit 82: QIAGEN NV - Vendor overview
  • Exhibit 83: QIAGEN NV - Business segments
  • Exhibit 84: QIAGEN NV - Organizational developments
  • Exhibit 85: QIAGEN NV - Geographic focus
  • Exhibit 86: QIAGEN NV - Segment focus
  • Exhibit 87: QIAGEN NV - Key offerings
  • Exhibit 88: Shimadzu Corp. - Vendor overview
  • Exhibit 89: Shimadzu Corp. - Business segments
  • Exhibit 90: Shimadzu Corp. - Organizational developments
  • Exhibit 91: Shimadzu Corp. - Geographic focus
  • Exhibit 92: Shimadzu Corp. - Segment focus
  • Exhibit 93: Shimadzu Corp. - Key offerings
  • Exhibit 94: Siemens AG - Vendor overview
  • Exhibit 95: Siemens AG - Business segments
  • Exhibit 96: Siemens AG - Organizational developments
  • Exhibit 97: Siemens AG - Geographic focus
  • Exhibit 98: Siemens AG - Segment focus
  • Exhibit 99: Siemens AG - Key offerings
  • Exhibit 100: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 101: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 102: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 103: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 104: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 105: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 106: Validation techniques employed for market sizing
  • Exhibit 107: Definition of market positioning of vendors
Back to Top